Geovax Labs (GOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,850 | 27,613 | 34,677 | 30,903 | 16,258 |
| Receivables | N/A | N/A | N/A | N/A | 100 |
| TOTAL | $25,989 | $28,939 | $36,137 | $32,038 | $16,637 |
| Non-Current Assets | |||||
| PPE Net | 218 | 235 | 249 | 215 | 207 |
| Other Non-Current Assets | 1,198 | 2,174 | 2,184 | 988 | 11 |
| TOTAL | $1,415 | $2,409 | $2,433 | $1,202 | $218 |
| Total Assets | $27,404 | $31,348 | $38,570 | $33,241 | $16,855 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,288 | 1,748 | 1,079 | 237 | 426 |
| Accrued Expenses | 3,251 | 3,000 | 3,710 | 3,131 | 3,075 |
| TOTAL | $4,539 | $4,748 | $4,789 | $3,368 | $3,501 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 2,000 | 2,000 | 2,000 |
| TOTAL | $N/A | $N/A | $2,000 | $2,000 | $2,000 |
| Total Liabilities | $4,539 | $4,748 | $6,789 | $5,368 | $5,501 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,764 | 1,757 | 1,757 | 1,650 | 630 |
| Common Shares | 26 | 2 | 26 | 16 | 9 |
| Retained earnings | -82,435 | -78,397 | -73,013 | -69,045 | -66,803 |
| TOTAL | $22,865 | $26,600 | $31,781 | $27,873 | $11,354 |
| Total Liabilities And Equity | $27,404 | $31,348 | $38,570 | $33,241 | $16,855 |